Showing results (121-130 of 723) with videos related to

Sort By:
Pageof 73
British Journal of Pharmacology|April 10, 2003
Differences in troglitazone action on glucose metabolism in freshly isolated vs long-term incubated rat skeletal muscleFlorian Gras, Barbara Brunmair, Michael Roden, et al.
Clinical Liver Disease|February 8, 2021
Nonalcoholic Fatty Liver Disease and Cardiovascular DiseaseEric M Przybyszewski, Giovanni Targher, Michael Roden, et al.
Clinical Chemistry|October 2, 2004
Relationship between serum lipoprotein ratios and insulin resistance in obesityAttila Brehm, Georg Pfeiler, Giovanni Pacini, et al.
Clinics in Liver Disease|May 16, 2026
Treatment of Modifiable Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease: Drugs Targeting Obesity and Type 2 DiabetesSonal Kumar, Maria Paula Macedo, Michael Roden, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 6, 2018
Severe Vitamin D3 Deficiency in the Majority of Patients with Diabetic Foot UlcersJoachim Feldkamp, Karsten Jungheim, Matthias Schott, et al.
Hepatology (Baltimore, Md.)|December 1, 2005
Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-kappab to activate hepatic apoptosis in genetically obese miceMarie-Anne Robin, Christine Demeilliers, Angéla Sutton, et al.
Toxicology and Applied Pharmacology|February 15, 2014
Chronic exposure to low doses of pharmaceuticals disturbs the hepatic expression of circadian genes in lean and obese miceSébastien Anthérieu, Dounia Le Guillou, Cédric Coulouarn, et al.
Liver|September 26, 2002
Inhibition of glucose production and stimulation of bile flow by R (+)-alpha-lipoic acid enantiomer in rat liverChristian Anderwald, Georg Koca, Clemens Fürnsinn, et al.
Pageof 73